Use of tylvalosin as antiviral agent
US9649324B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 8, 2015 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Jun 8, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.